DEK

Across TCGA pan-cancer cohorts, DEK Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DEK data layer compared with 24 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher DEK Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated DEK expression acts as an unfavorable survival marker, although some lineages such as STAD and UCEC show a favorable association.

STAD, BLCA, and UCEC are the cancer types where DEK Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Median	III,IV	1.000	0.334	.024	9	view →
BLCA	DFS	Median	IV	0.077	0.476	<.001	6	view →
UCEC	DFS	Median	All	0.954	0.627	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

DEK–STAD (DFS)

Open the STAD breakdown →